NCT07052851View on ClinicalTrials.gov

Performance of CCoat Intra-Articular Injections in Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Double-Blind, Multi-center Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

January 31, 2027

Conditions
Osteoarthritis, Knee
Interventions
DEVICE

CCoat, Liposphere Ltd

a single IA injection of 4 ml CCoat

DEVICE

Synvisc-One® (hylan G-F 20)

Group 2 (Active Comparator): a single IA Synvisc-One® (hylan G-F 20) of 6 mL, Genzyme Corporation

Sponsors

Lead Sponsor

Lipo-Sphere
All Listed Sponsors
lead

Lipo-Sphere

INDUSTRY